Source abstract
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to "Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent"Kwang Hee SonKwang Hee SonPreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaSchool of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of KoreaSchool of Life Sciences & Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of KoreaMore by Kwang Hee Son, Da Sol LeeDa Sol LeePreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by Da Sol Lee, Geumi ParkGeumi ParkPreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by Geumi Park, So Yeon JeonSo Yeon JeonPreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by So Yeon Jeon, Jae-Eon LeeJae-Eon LeePreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by Jae-Eon Lee, Hui-Jeon JeonHui-Jeon JeonNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by Hui-Jeon Jeon, Sijoon LeeSijoon LeePreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by Sijoon Lee, Woo-Jin ParkWoo-Jin ParkDepartment of Chemistry, Center for NanoMedicine, Institute for Basic Science (IBS), Seoul 03722, Republic of KoreaMore by Woo-Jin Park, Yeonju ShinYeonju ShinTherapeutics and Biotechnology Division, Korea Research, Institute of Chemical Technology, 141 Gajeongro, Yuseong, Daejeon 31414, South KoreaMore by Yeonju Shin, Seong Gon KimSeong Gon KimTherapeutics and Biotechnology Division, Korea Research, Institute of Chemical Technology, 141 Gajeongro, Yuseong, Daejeon 31414, South KoreaMore by Seong Gon Kim, Dong-Seok LeeDong-Seok LeeSchool of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of KoreaSchool of Life Sciences & Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of KoreaMore by Dong-Seok Lee, Ye Ri Han*Ye Ri HanNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by Ye Ri Hanhttps://orcid.org/0000-0002-5415-3008, Dong-Su Kim*Dong-Su KimTherapeutics and Biotechnology Division, Korea Research, Institute of Chemical Technology, 141 Gajeongro, Yuseong, Daejeon 31414, South KoreaMore by Dong-Su Kimhttps://orcid.org/0000-0003-0388-4633, and Yong Hyun Jeon*Yong Hyun JeonPreclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of KoreaMore by Yong Hyun Jeonhttps://orcid.org/0000-0003-3161-7698Cite this: ACS Appl. Mater. Interfaces 2024, 16, 13, 17062Publication Date (Web):March 21, 2024Publication History Received7 March 2024Published online21 March 2024Published inissue 3 April 2024https://pubs.acs.org/doi/10.1021/acsami.4c03839https://doi.org/10.1021/acsami.4c03839correctionACS PublicationsCopyright © 2024 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views195Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (768 KB) Get e-Alertsclose Get e-Alerts
Source: openalex_inverted_index · Quality: baseline
Affiliations
Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea
School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea
School of Life Sciences & Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea
New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea
Department of Chemistry, Center for NanoMedicine, Institute for Basic Science (IBS), Seoul 03722, Republic of Korea
Therapeutics and Biotechnology Division, Korea Research, Institute of Chemical Technology, 141 Gajeongro, Yuseong, Daejeon 31414, South Korea
Funding
Korea Health Industry Development Institute · Ministry of Health and Welfare · Korea Research Institute of Chemical Technology · National Research Foundation of Korea